Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Abstract Measurable residual disease (MRD; previously termed minimal residual disease) is an independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) tha...